Gonadal dysfunction and fertility problems in cancer survivors
- PMID: 17497315
- DOI: 10.1080/02841860601166958
Gonadal dysfunction and fertility problems in cancer survivors
Abstract
Gonadal dysfunction and fertility problems are adverse effects of cancer treatment or may be associated with specific malignancies. This review focuses on these problems in the young cancer survivors, where methods of protecting or restoring endocrine function and fertility need to be considered. In females, treatment adverse effects can result in infertility, but premature ovarian failure (POF) is probably relevant for more female cancer survivors, affecting also those who do not wish post-treatment parenthood. POF affects present and future health, especially through oestrogen deficiency symptoms and an increased risk of developing osteoporosis. A lower risk of developing POF has been considered in young females than in older due to a larger pool of oocytes. However, a recent long-term follow-up study reported a prevalence of POF in young females with Hodgkin's lymphoma of 37% showing that young age at time of treatment only delays the development of POF. In male gonads, germ cells are much more sensitive to irradiation and chemotherapy than Leydig cells. Thus, infertility is a more common adverse effect than hypogonadism. Some malignancies are particular relevant. Persistent azoospermia was formerly common after treatment for Hodgkin's lymphoma, but currently, most patients recover spermatogenesis. Modern treatment of childhood acute lymphoblastic leukemia is also unlikely to cause infertility. Norwegian testicular cancer survivors diagnosed in 1980-1994 who attempted conception had an overall 15-year actuarial post-treatment paternity rate of 71% (range 48-92% depending on the treatment). However, the rate was significantly higher among men diagnosed in1989-1994 (over 80%) than in 1980-1988 (about 63%). Patients at risk for hypogonadism and infertility should be defined prior to treatment, and available methods for gonadal preservation should maximally be utilised. During follow-up, oncologists should routinely address these issues.
Similar articles
-
Male infertility in cancer patients: Review of the literature.Int J Urol. 2010 Apr;17(4):327-31. doi: 10.1111/j.1442-2042.2010.02484.x. Epub 2010 Feb 22. Int J Urol. 2010. PMID: 20202000 Review.
-
Long-term endocrine side effects of childhood Hodgkin's lymphoma treatment: a review.Hum Reprod Update. 2012 Jan-Feb;18(1):12-28. doi: 10.1093/humupd/dmr038. Epub 2011 Sep 6. Hum Reprod Update. 2012. PMID: 21896559 Review.
-
Effect of childhood cancer treatment on fertility markers in adult male long-term survivors.Pediatr Blood Cancer. 2009 Jan;52(1):108-12. doi: 10.1002/pbc.21780. Pediatr Blood Cancer. 2009. PMID: 18819129
-
Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study.Pediatr Blood Cancer. 2012 Aug;59(2):271-7. doi: 10.1002/pbc.23363. Epub 2011 Oct 20. Pediatr Blood Cancer. 2012. PMID: 22021108
-
Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study.J Clin Oncol. 2012 Jan 20;30(3):291-9. doi: 10.1200/JCO.2011.37.1989. Epub 2011 Dec 19. J Clin Oncol. 2012. PMID: 22184372
Cited by
-
Effects of Subacute Administration of Co-Trimoxazole and Folic Acid on Ovarian Tissue in Adult Female Rats.Iran J Med Sci. 2017 Nov;42(6):561-568. Iran J Med Sci. 2017. PMID: 29184264 Free PMC article.
-
Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial.PLoS Med. 2019 Nov 12;16(11):e1002960. doi: 10.1371/journal.pmed.1002960. eCollection 2019 Nov. PLoS Med. 2019. PMID: 31714912 Free PMC article. Clinical Trial.
-
[Hodgkin's lymphoma during childhood and adolescence: parenthood rates not lower after radiation treatment outside the pelvis].Strahlenther Onkol. 2015 Dec;191(12):994-6. doi: 10.1007/s00066-015-0907-2. Strahlenther Onkol. 2015. PMID: 26466950 German. No abstract available.
-
Evaluation of external contamination on the vial surfaces of some hazardous drugs that commonly used in Chinese hospitals and comparison between environmental contamination generated during robotic compounding by IV: Dispensing robot vs. manual compounding in biological safety cabinet.J Oncol Pharm Pract. 2022 Oct;28(7):1487-1498. doi: 10.1177/10781552211023571. Epub 2021 Jun 24. J Oncol Pharm Pract. 2022. PMID: 34162245 Free PMC article.
-
Nanoparticle-Based Drug Delivery System: A Patient-Friendly Chemotherapy for Oncology.Dose Response. 2020 Jul 10;18(3):1559325820936161. doi: 10.1177/1559325820936161. eCollection 2020 Jul-Sep. Dose Response. 2020. PMID: 32699536 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical